Clinic
Iha Health Services Corporation
Iha Health Services Corporation was paid $9.12M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoIHA HEALTH SERVICES CORPORATION
ANN ARBOR, MI 48105
ANN ARBOR, MI 48105
33aNPI1992937023assigned 08/24/2009
33bProvider typeUrgent Care Clinic/Center
28Total paid$9.12M
24GClaims234,789
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Michigan
Rank by total paid#4 of 239
Median peer was paid$346K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,903 | $306K | |
| 2019 | 10,270 | $363K | |
| 2020 | 16,382 | $534K | |
| 2021 | 32,257 | $1.16M | |
| 2022 | 41,503 | $1.54M | |
| 2023 | 56,724 | $2.14M | |
| 2024incomplete | 68,750 | $3.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 72,745 | 68,978 | $3.61M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 24,780 | 24,171 | $1.64M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 17% | 23,493 | 23,436 | $1.52M |
| 87428 | 7.3% | 18,289 | 18,022 | $667K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.8% | 5,578 | 5,565 | $528K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.9% | 20,830 | 20,464 | $262K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 6,111 | 5,936 | $189K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.6% | 3,592 | 3,579 | $148K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.4% | 1,071 | 1,050 | $124K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 4,025 | 3,919 | $122K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,895 | 5,618 | $44K |
| 81025 | <1% | 5,909 | 5,811 | $38K |
51 more codes
| 99000 | <1% | 5,061 | $27K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,957 | $26K |
| 81003 | <1% | 12,486 | $21K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 531 | $19K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 556 | $17K |
| 93000 | <1% | 2,027 | $16K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,176 | $15K |
| 90715 | <1% | 467 | $12K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,062 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,542 | $9K |
| 12001 | <1% | 127 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 474 | $6K |
| 87400 | <1% | 764 | $6K | |
| 10060 | <1% | 57 | $4K | |
| 86308 | <1% | 774 | $3K | |
| 0240U | <1% | 227 | $2K | |
| 82962 | <1% | 954 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,744 | $2K |
| 0012A | <1% | 55 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 357 | $2K |
| 0011A | <1% | 79 | $2K | |
| 81002 | <1% | 577 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,239 | $1K |
| 99201 | <1% | 41 | $1K | |
| 12002 | <1% | 13 | $963.49 | |
| 0001A | <1% | 46 | $930.34 | |
| 0002A | <1% | 31 | $918.55 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 809 | $782.84 |
| 86580 | <1% | 122 | $727.50 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 220 | $721.11 |
| 36415 | Collection of venous blood by venipuncture | <1% | 224 | $717.03 |
| 72100 | <1% | 15 | $190.75 | |
| 90686 | <1% | 20 | $171.27 | |
| 69209 | <1% | 25 | $167.08 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 29 | $160.47 |
| S9083 | Global fee urgent care centers | <1% | 114 | $151.00 |
| 15853 | <1% | 16 | $112.64 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 667 | $82.50 |
| 99051 | <1% | 611 | $30.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 542 | $22.50 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 172 | $4.66 |
| 3078F | 0% | 716 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 67 | $0.00 |
| 3077F | 0% | 24 | $0.00 | |
| 3074F | 0% | 840 | $0.00 | |
| 3008F | 0% | 1,254 | $0.00 | |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 138 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 51 | $0.00 |
| 3079F | 0% | 274 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 37 | $0.00 |
| 3075F | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELLIOTT, CYNTIA (CHIEF OPERATING OFFICER)